Browse All

Current Filters

CLEAR FILTER x

TITLE

Estimating the 10-Year Time-savings Benefits of Lecanemab Treatment

Author:Whetten, John   Dickson, Samuel   Duncan, Garrett   Hendrix, Suzanne   Youmans-Kidder, Katherine   Jones, Daryl   

Session Name:S1: New Perspectives on Alzheimer's Therapeutics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S1.006  

Author Institution:Pentara Corporation, Millcreek, UT  Eisai Inc., Chicago, IL  Eisai Inc., Nutley, NJ  

CMT-HI Upper Limb Subscale Scores Respond to Treatment With Govorestat in Patients With CMT-SORD

Author:Bailey, Evan   Heatwole, Chad   Luth, Jennifer   Summers, Catherine   Dickson, Samuel   Dayley, Caleb   Shy, Michael   

Session Name:S2: Updates on Motor Neuron and Peripheral Nerve Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S2.007  

Author Institution:Applied Therapeutics, New York, NY  University of Rochester Medical Center, Rochester, NY  Applied Therapeutics, NY  Pentara Corporation, Millcreek, UT  Pentara Corporation, UT  University of Iowa, Iowa City, IA  

Long-term Benefit of Lecanemab in Patients with Low Baseline Amyloid: Estimation of Time Saved

Author:Dickson, Samuel   Whetten, John   Hendrix, Suzanne   Youmans-Kidder, Katherine   Jones, Daryl   

Session Name:P2: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease and Anti-amyloid Therapies 2  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P2.003  

Author Institution:Pentara Corporation, Millcreek, UT  Eisai Inc., Chicago, IL  Eisai Inc., Nutley, NJ